FRESH-PEF67-en
CHOICE: CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy
CHOICE
| Name | Country code |
|---|---|
| France | fr |
| Germany | de |
| Sweden | se |
| Denmark | dk |
| Belgium | be |
| Greece | gr |
['Clinical data','Biological data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Endocrinology | health theme |
| Healthcare system determinants: Use of care | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Adults 18 years and older, - Type-2 diabetes patients who have never received insulin or exenatide and who are initiating a treatment via exenatide or insulin therapy, within the normal routine course of care.","clusion_E":""}
| Name | Role |
|---|---|
| LILLY FRANCE | sponsor |
| Name |
|---|
| LILLY FRANCE |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)','Through independent healthcare practitioners']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2008-01-01 | 2012-01-01 |
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}